Chlamydia trachomatis and Mycoplasma infection
Conditions
Interventions
Baofukang suppository treatment group:Baofukang suppository treatment
Azithromycin control group:Azithromycin
Sponsors
Peking University Shenzhen Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 39 Years
Inclusion criteria
Inclusion criteria: 1. Have sex, aged 20 to 39 years; 2. No oral use of systemic antibiotics or topical vaginal medication within 3 months; 3. All patients require clean menstruation for 3-7 days (follicular phase), no vaginal medication, no sexual life after menstruation, and positive for Mycoplasma (culture method) and (or) Chlamydia trachomatis (enzyme-linked immunosorbent assay); 4. Those who agree to use Baofukang suppository for treatment; 5. Those who agree to use azithromycin therapy.
Exclusion criteria
Exclusion criteria: 1. Local vaginal damage; 2. Allergy to Baofukang suppository/azithromycin; 3. Patients with specific infections such as Trichomonas vaginalis, Candida, and Neisseria gonorrhoeae, or patients with acute and chronic infectious diseases of the systemic and reproductive tracts, liver and kidney dysfunction, or patients with severe systemic diseases, immunosuppressants, diabetes, or abnormal glucose tolerance other comorbidities; 4. Unwilling to sign informed consent and unable to cooperate with follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mycoplasma;Chlamydia trachomatis;adverse event; | — |
Countries
China
Contacts
Public ContactTang Huiru
Peking University Shenzhen Hospital
Outcome results
None listed